Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118780529 | 11878052 | 9 | F | 201511 | 20160713 | 20151230 | 20160722 | EXP | GB-AMGEN-GBRSP2015111197 | AMGEN | 59.00 | YR | A | F | Y | 0.00000 | 20160722 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118780529 | 11878052 | 1 | PS | PROLIA | DENOSUMAB | 1 | Subcutaneous | UNK | U | 125320 | SOLUTION FOR INJECTION | ||||||||
| 118780529 | 11878052 | 2 | SS | XGEVA | DENOSUMAB | 1 | Unknown | UNK | U | 0 | UNKNOWN FORMULATION | ||||||||
| 118780529 | 11878052 | 3 | C | ORAMORPH | MORPHINE SULFATE | 1 | 0 | ||||||||||||
| 118780529 | 11878052 | 4 | C | PARACETAMOL | ACETAMINOPHEN | 1 | 4 TIMES A DAY | 0 | |||||||||||
| 118780529 | 11878052 | 5 | C | ADCAL D3 | CALCIUM CARBONATECHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 118780529 | 11878052 | 6 | C | CARBOPLATIN. | CARBOPLATIN | 1 | 0 | ||||||||||||
| 118780529 | 11878052 | 7 | C | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118780529 | 11878052 | 1 | Product used for unknown indication |
| 118780529 | 11878052 | 2 | Product used for unknown indication |
| 118780529 | 11878052 | 3 | Breakthrough pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118780529 | 11878052 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118780529 | 11878052 | Arthralgia | |
| 118780529 | 11878052 | Asthenia | |
| 118780529 | 11878052 | Back pain | |
| 118780529 | 11878052 | Blood calcium abnormal | |
| 118780529 | 11878052 | Blood calcium increased | |
| 118780529 | 11878052 | Blood pressure increased | |
| 118780529 | 11878052 | Bone pain | |
| 118780529 | 11878052 | Breakthrough pain | |
| 118780529 | 11878052 | Catheter site erythema | |
| 118780529 | 11878052 | Chapped lips | |
| 118780529 | 11878052 | Chest pain | |
| 118780529 | 11878052 | Complication associated with device | |
| 118780529 | 11878052 | Constipation | |
| 118780529 | 11878052 | Cough | |
| 118780529 | 11878052 | Decreased appetite | |
| 118780529 | 11878052 | Diarrhoea | |
| 118780529 | 11878052 | Discomfort | |
| 118780529 | 11878052 | Dry mouth | |
| 118780529 | 11878052 | Dry skin | |
| 118780529 | 11878052 | Dysgeusia | |
| 118780529 | 11878052 | Dyspnoea exertional | |
| 118780529 | 11878052 | Fatigue | |
| 118780529 | 11878052 | Gingival pain | |
| 118780529 | 11878052 | Hypoaesthesia | |
| 118780529 | 11878052 | Mobility decreased | |
| 118780529 | 11878052 | Musculoskeletal chest pain | |
| 118780529 | 11878052 | Nausea | |
| 118780529 | 11878052 | Neuralgia | |
| 118780529 | 11878052 | Neuropathy peripheral | |
| 118780529 | 11878052 | Oral pain | |
| 118780529 | 11878052 | Pain | |
| 118780529 | 11878052 | Pain in extremity | |
| 118780529 | 11878052 | Platelet count decreased | |
| 118780529 | 11878052 | Pruritus | |
| 118780529 | 11878052 | Rhinorrhoea | |
| 118780529 | 11878052 | Sleep disorder | |
| 118780529 | 11878052 | Sleep disorder due to a general medical condition | |
| 118780529 | 11878052 | Tooth abscess | |
| 118780529 | 11878052 | Tooth loss | |
| 118780529 | 11878052 | Tremor | |
| 118780529 | 11878052 | Upper-airway cough syndrome | |
| 118780529 | 11878052 | Vein disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |